Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$17.5M
Filings
162
Firms Hired
5
Active Period
1999–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
S.1296, H.R. 1048, Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions Act, DETERRENT Act;
Client expense: $340,000 · Firm income: —
Matched citations: H.R. 1048
S. 2355 Patients Deserve Price Tags Act, Health care policy; Telehealth; U.S. Family Health Plan; H.R. 9599, Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act, S.5244, Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the future of 340B Act, 340B; H.R. 9790, Modernizing Opiod Treatment Access Act 2.0, S.4941, Modernizing Opiod Treatment Access Act 2.0, MOTAA 2.0
Client expense: $340,000 · Firm income: —
Matched citations: H.R. 9599
Modernizing Opioid Treatment Access Act 2.0 of 2026
2026 · third_quarter · Firm: JOHNS HOPKINS UNIVERSITY
S. 2355 Patients Deserve Price Tags Act, Health care policy; Telehealth; U.S. Family Health Plan; H.R. 9599, Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act, S.5244, Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the future of 340B Act, 340B; H.R. 9790, Modernizing Opiod Treatment Access Act 2.0, S.4941, Modernizing Opiod Treatment Access Act 2.0, MOTAA 2.0
Client expense: $340,000 · Firm income: —
Matched citations: H.R. 9790
S.1296, H.R. 1048, Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions Act, DETERRENT Act;
Client expense: $340,000 · Firm income: —
Matched citations: S.1296
Patients Deserve Price Tags Act
2026 · third_quarter · Firm: JOHNS HOPKINS UNIVERSITY
S. 2355 Patients Deserve Price Tags Act, Health care policy; Telehealth; U.S. Family Health Plan; H.R. 9599, Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act, S.5244, Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the future of 340B Act, 340B; H.R. 9790, Modernizing Opiod Treatment Access Act 2.0, S.4941, Modernizing Opiod Treatment Access Act 2.0, MOTAA 2.0
Client expense: $340,000 · Firm income: —
Matched citations: S. 2355
Modernizing Opioid Treatment Access Act 2.0 of 2026
2026 · third_quarter · Firm: JOHNS HOPKINS UNIVERSITY
S. 2355 Patients Deserve Price Tags Act, Health care policy; Telehealth; U.S. Family Health Plan; H.R. 9599, Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act, S.5244, Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the future of 340B Act, 340B; H.R. 9790, Modernizing Opiod Treatment Access Act 2.0, S.4941, Modernizing Opiod Treatment Access Act 2.0, MOTAA 2.0
Client expense: $340,000 · Firm income: —
Matched citations: S.4941
Accreditation Reform and Enhanced Accountability Act of 2026
2026 · third_quarter · Firm: JOHNS HOPKINS UNIVERSITY
P.L. 119-21, One Big Beautiful Bill Act, Federal student loan changes; Higher Education Policy; S. 5053, Accreditation Reform and Enhanced Accountability Act of 2026, Higher education accreditation;
Client expense: $340,000 · Firm income: —
Matched citations: S. 5053
S. 2355 Patients Deserve Price Tags Act, Health care policy; Telehealth; U.S. Family Health Plan; H.R. 9599, Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act, S.5244, Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the future of 340B Act, 340B; H.R. 9790, Modernizing Opiod Treatment Access Act 2.0, S.4941, Modernizing Opiod Treatment Access Act 2.0, MOTAA 2.0
Client expense: $340,000 · Firm income: —
Matched citations: S.5244
DETERRENT Act
2026 · third_quarter · Firm: CORNERSTONE GOVERNMENT AFFAIRS, INC.
Artificial Intelligence; Research security; S.854/H.R. 1864 - Risky Research Review Act; H.R. 1048/S.1296 - the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act; H.R. 9102, the Biotech Investment National Security Act of 2026
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1048
Risky Research Review Act
2026 · third_quarter · Firm: CORNERSTONE GOVERNMENT AFFAIRS, INC.
Artificial Intelligence; Research security; S.854/H.R. 1864 - Risky Research Review Act; H.R. 1048/S.1296 - the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act; H.R. 9102, the Biotech Investment National Security Act of 2026
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1864
Healthy Competition for Better Care Act
2026 · third_quarter · Firm: CORNERSTONE GOVERNMENT AFFAIRS, INC.
H.R. 9393, the Lower Costs, More Transparency Act of 2026; H.R. 9390, the Prices on the Wall Act of 2026; H.R. 6248/S.4027, the Healthy Competition For Better Care Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6248
Artificial Intelligence; Research security; S.854/H.R. 1864 - Risky Research Review Act; H.R. 1048/S.1296 - the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act; H.R. 9102, the Biotech Investment National Security Act of 2026
Client expense: — · Firm income: $60,000
Matched citations: H.R. 9102
Prices on the Wall Act of 2026
2026 · third_quarter · Firm: CORNERSTONE GOVERNMENT AFFAIRS, INC.
H.R. 9393, the Lower Costs, More Transparency Act of 2026; H.R. 9390, the Prices on the Wall Act of 2026; H.R. 6248/S.4027, the Healthy Competition For Better Care Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 9390
Lower Costs, More Transparency Act of 2026
2026 · third_quarter · Firm: CORNERSTONE GOVERNMENT AFFAIRS, INC.
H.R. 9393, the Lower Costs, More Transparency Act of 2026; H.R. 9390, the Prices on the Wall Act of 2026; H.R. 6248/S.4027, the Healthy Competition For Better Care Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 9393
Tax Exempt Hospital Transparency Act
2026 · third_quarter · Firm: CORNERSTONE GOVERNMENT AFFAIRS, INC.
Tax-exempt status for nonprofit organizations; H.R. 9504, the Tax-exempt Hospital Transparency Act; H.R. 9772, the Foreign Funding Transparency Act; H.R. 9721, the Fiscal Sponsorship Transparency Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 9504
Fiscal Sponsorship Transparency Act of 2026
2026 · third_quarter · Firm: CORNERSTONE GOVERNMENT AFFAIRS, INC.
Tax-exempt status for nonprofit organizations; H.R. 9504, the Tax-exempt Hospital Transparency Act; H.R. 9772, the Foreign Funding Transparency Act; H.R. 9721, the Fiscal Sponsorship Transparency Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 9721
Foreign Funding Transparency Act
2026 · third_quarter · Firm: CORNERSTONE GOVERNMENT AFFAIRS, INC.
Tax-exempt status for nonprofit organizations; H.R. 9504, the Tax-exempt Hospital Transparency Act; H.R. 9772, the Foreign Funding Transparency Act; H.R. 9721, the Fiscal Sponsorship Transparency Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 9772
Artificial Intelligence; Research security; S.854/H.R. 1864 - Risky Research Review Act; H.R. 1048/S.1296 - the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act; H.R. 9102, the Biotech Investment National Security Act of 2026
Client expense: — · Firm income: $60,000
Matched citations: S.1296
Healthy Competition for Better Care Act
2026 · third_quarter · Firm: CORNERSTONE GOVERNMENT AFFAIRS, INC.
H.R. 9393, the Lower Costs, More Transparency Act of 2026; H.R. 9390, the Prices on the Wall Act of 2026; H.R. 6248/S.4027, the Healthy Competition For Better Care Act
Client expense: — · Firm income: $60,000
Matched citations: S.4027
Risky Research Review Act
2026 · third_quarter · Firm: CORNERSTONE GOVERNMENT AFFAIRS, INC.
Artificial Intelligence; Research security; S.854/H.R. 1864 - Risky Research Review Act; H.R. 1048/S.1296 - the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act; H.R. 9102, the Biotech Investment National Security Act of 2026
Client expense: — · Firm income: $60,000
Matched citations: S.854
DETERRENT Act
2026 · third_quarter · Firm: CORNERSTONE GOVERNMENT AFFAIRS, INC.
Artificial Intelligence; Research security; S.854/H.R. 1864 - Risky Research Review Act; H.R. 1048/S.1296 - the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act; H.R. 9102, the Biotech Investment National Security Act of 2026
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1048
Risky Research Review Act
2026 · third_quarter · Firm: CORNERSTONE GOVERNMENT AFFAIRS, INC.
Artificial Intelligence; Research security; S.854/H.R. 1864 - Risky Research Review Act; H.R. 1048/S.1296 - the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act; H.R. 9102, the Biotech Investment National Security Act of 2026
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1864
Healthy Competition for Better Care Act
2026 · third_quarter · Firm: CORNERSTONE GOVERNMENT AFFAIRS, INC.
H.R. 9393, the Lower Costs, More Transparency Act of 2026; H.R. 9390, the Prices on the Wall Act of 2026; H.R. 6248/S.4027, the Healthy Competition For Better Care Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6248
Artificial Intelligence; Research security; S.854/H.R. 1864 - Risky Research Review Act; H.R. 1048/S.1296 - the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act; H.R. 9102, the Biotech Investment National Security Act of 2026
Client expense: — · Firm income: $60,000
Matched citations: H.R. 9102
Prices on the Wall Act of 2026
2026 · third_quarter · Firm: CORNERSTONE GOVERNMENT AFFAIRS, INC.
H.R. 9393, the Lower Costs, More Transparency Act of 2026; H.R. 9390, the Prices on the Wall Act of 2026; H.R. 6248/S.4027, the Healthy Competition For Better Care Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 9390
Source: Senate LDA